Hanan Salem

Hanan Salem

Auto-generated profile, based on publicly available information

Hanan Salem

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
ZCZhaoyang Chen
Zhaoyang Chen
MMMitsuaki Matsumura
Mitsuaki Matsumura
GMGary S. Mintz
Gary S. Mintz
MNMasahiko Noguchi
Masahiko Noguchi
TFTatsuhiro Fujimura
Tatsuhiro Fujimura
AMAkiko Maehara
Akiko Maehara
Background: Clinical and morphological factors associated with lipidic versus calcified neoatherosclerosis within second-generation drug-eluting stents and the impact of lipidic versus calcified neoatherosclerosis on long-term outcomes after repeat intervention have not been well studied. Methods: A total of 512 patients undergoing optical coherence tomography before percutaneous coronary intervention for second-generation drug-eluting stents in-stent restenosis were included. Neoatherosclerosis was defined as lipidic or calcified neointimal hyperplasia in ≥3 consecutive frames or ruptured lipidic neointimal hyperplasia. The primary outcome was target lesion failure (cardiac death, target vessel myocardial infarction, definite stent thrombosis, or clinically driven target lesion revascularization). Results: The overall prevalence of neoatherosclerosis was 28.5% (146/512): 56.8% lipidic, 30.8% calcified, and 12.3% both lipidic and calcific. The prevalence increased as a function of time from stent implantation: 20% at 1 to 3 years, 30% at 3 to 7 years, and 75% >7 years. Renal insufficiency, poor lipid profile, and time from stent implantation were associated with lipidic neoatherosclerosis, whereas severe renal insufficiency, female sex, and time from stent implantation were associated with calcified neoatherosclerosis. Multivariable Cox regression revealed that female sex and lipidic neoatherosclerosis were associated with more target lesion failure, whereas stent age and final minimum lumen diameter after reintervention were related to lower target lesion failure. Calcified neoatherosclerosis was not related to adverse events after reintervention for in-stent restenosis given a large enough minimum lumen diameter was achieved. Conclusions: Lipidic but not calcified neoatherosclerosis was associated with poor subsequent outcomes after repeat revascularization if optimal stent expansion was achieved in lesions with calcified neoatherosclerosis.

12 October 2022 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MNMasahiko Noguchi
Masahiko Noguchi
FGFotios Gkargkoulas
Fotios Gkargkoulas
MMMitsuaki Matsumura
Mitsuaki Matsumura
LKLak N. Kotinkaduwa
Lak N. Kotinkaduwa
XHXun Hu
Xun Hu
AMAkiko Maehara
Akiko Maehara

14 April 2022 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
HSHanan Salem
Hanan Salem
GMGary S. Mintz
Gary S. Mintz
MMMitsuaki Matsumura
Mitsuaki Matsumura
MZMingyou Zhang
Mingyou Zhang
EUEisuke Usui
Eisuke Usui
AMAkiko Maehara
Akiko Maehara